Showing results (31-40 of 53) with videos related to

Sort By:
Pageof 6
Cells|July 27, 2022
A Drug Repurposing Screen Identifies Fludarabine Phosphate as a Potential Therapeutic Agent for N-MYC Overexpressing Neuroendocrine Prostate CancersHussain Elhasasna, Raymond Khan, Kalpana K Bhanumathy, et al.
BMC Infectious Diseases|July 8, 2021
Identification of novel genes involved in apoptosis of HIV-infected macrophages using unbiased genome-wide screeningSimon X M Dong, Frederick S Vizeacoumar, Kalpana K Bhanumathy, et al.
Breast Cancer Research : BCR|January 27, 2016
Epigenetic silencing of CREB3L1 by DNA methylation is associated with high-grade metastatic breast cancers with poor prognosis and is prevalent in triple negative breast cancersAlison K Ward, Paul Mellor, Shari E Smith, et al.
Cell Reports|July 1, 2023
Integration of cancer-related genetic landscape of Eph receptors and ephrins with proteomics identifies a crosstalk between EPHB6 and EGFRGlinton Hanover, Frederick S Vizeacoumar, Sara L Banerjee, et al.
Oncotarget|July 16, 2016
Targeting synthetic lethality between the SRC kinase and the EPHB6 receptor may benefit cancer treatmentJames M Paul, Behzad Toosi, Frederick S Vizeacoumar, et al.
Nature Communications|January 8, 2024
hnRNP A1 dysfunction alters RNA splicing and drives neurodegeneration in multiple sclerosis (MS)Hannah E Salapa, Patricia A Thibault, Cole D Libner, et al.
Elife|April 19, 2024
MEMO1 binds iron and modulates iron homeostasis in cancer cellsNatalia Dolgova, Eva-Maria E Uhlemann, Michal T Boniecki, et al.
The Journal of Cell Biology|January 13, 2010
Integrating high-throughput genetic interaction mapping and high-content screening to explore yeast spindle morphogenesisFranco J Vizeacoumar, Nydia van Dyk, Frederick S Vizeacoumar, et al.
Molecular Oncology|December 15, 2018
Molecular characterization of an MLL1 fusion and its role in chromosomal instabilitySreejit Parameswaran, Frederick S Vizeacoumar, Kalpana Kalyanasundaram Bhanumathy, et al.
Cancers|September 9, 2022
Activation of the Anaphase Promoting Complex Reverses Multiple Drug Resistant Cancer in a Canine Model of Multiple Drug Resistant LymphomaTerra G Arnason, Valerie MacDonald-Dickinson, Matthew Casey Gaunt, et al.
Pageof 6